These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25848940)
1. EDB Fibronectin Specific Peptide for Prostate Cancer Targeting. Han Z; Zhou Z; Shi X; Wang J; Wu X; Sun D; Chen Y; Zhu H; Magi-Galluzzi C; Lu ZR Bioconjug Chem; 2015 May; 26(5):830-8. PubMed ID: 25848940 [TBL] [Abstract][Full Text] [Related]
2. EDB Fibronectin-Specific SPECT Probe Ye XX; Zhao YY; Wang Q; Xiao W; Zhao J; Peng YJ; Cao DH; Lin WJ; Si-Tu MY; Li MZ; Zhang X; Zhang WG; Xia YF; Yang X; Feng GK; Zeng MS ACS Omega; 2017 Jun; 2(6):2459-2468. PubMed ID: 30023665 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer. Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766 [TBL] [Abstract][Full Text] [Related]
4. Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI. Han Z; Li Y; Roelle S; Zhou Z; Liu Y; Sabatelle R; DeSanto A; Yu X; Zhu H; Magi-Galluzzi C; Lu ZR Bioconjug Chem; 2017 Apr; 28(4):1031-1040. PubMed ID: 28201871 [TBL] [Abstract][Full Text] [Related]
5. EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer. Li R; He H; Li X; Zheng X; Li Z; Zhang H; Ye J; Zhang W; Yu C; Feng G; Fan W Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2100-2113. PubMed ID: 36807768 [TBL] [Abstract][Full Text] [Related]
6. EDB-FN Targeted Peptide-Drug Conjugates for Use against Prostate Cancer. Park SE; Shamloo K; Kristedja TA; Darwish S; Bisoffi M; Parang K; Tiwari RK Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277465 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin. Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274 [TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of ZD2 Peptide Han Z; Sergeeva O; Roelle S; Cheng H; Gao S; Li Y; Lee Z; Lu ZR ACS Omega; 2019 Jan; 4(1):1185-1190. PubMed ID: 30729224 [TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts. Qiao P; Ayat NR; Vaidya A; Gao S; Sun W; Chou S; Han Z; Gilmore H; Winter JM; Lu ZR Front Oncol; 2020; 10():586727. PubMed ID: 33194740 [TBL] [Abstract][Full Text] [Related]
10. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice. Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060 [TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment. Han Z; Cheng H; Parvani JG; Zhou Z; Lu ZR Magn Reson Med; 2018 Jun; 79(6):3135-3143. PubMed ID: 29082597 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and assessment of ZD2-( Gao S; Qin J; Sergeeva O; Sergeev M; Qiao P; Roelle S; Avril N; Lee Z; Li Y; Lu Z Am J Nucl Med Mol Imaging; 2019; 9(5):216-229. PubMed ID: 31772820 [TBL] [Abstract][Full Text] [Related]
13. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer. Lu ZR; Laney V; Li Y Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350 [TBL] [Abstract][Full Text] [Related]
14. TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells. Ventura E; Weller M; Macnair W; Eschbach K; Beisel C; Cordazzo C; Claassen M; Zardi L; Burghardt I J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29158223 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer. Hall RC; Ayat NR; Qiao PL; Vaidya AM; Ma D; Aminoshariae A; Stojanov I; Lu ZR Mol Imaging Biol; 2020 Dec; 22(6):1532-1542. PubMed ID: 32789648 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells. Vaidya A; Wang H; Qian V; Gilmore H; Lu ZR Cells; 2020 Aug; 9(8):. PubMed ID: 32756405 [TBL] [Abstract][Full Text] [Related]
18. MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate Cancer. Vaidya A; Shankardass A; Buford M; Hall R; Qiao P; Wang H; Gao S; Huang J; Tweedle MF; Lu ZR Chem Biomed Imaging; 2024 Aug; 2(8):560-568. PubMed ID: 39211789 [TBL] [Abstract][Full Text] [Related]
19. Ultrasound Molecular Imaging of Bladder Cancer via Extradomain B Fibronectin-Targeted Biosynthetic GVs. Feng Y; Hao Y; Wang Y; Song W; Zhang S; Ni D; Yan F; Sun L Int J Nanomedicine; 2023; 18():4871-4884. PubMed ID: 37662687 [TBL] [Abstract][Full Text] [Related]
20. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]